Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
Stuart P. McCluskey, Christophe Plisson, Eugenii A. Rabiner, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 47, Iss. 2, pp. 451-489
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 184
The synaptic hypothesis of schizophrenia version III: a master mechanism
Oliver Howes, Ellis Chika Onwordi
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1843-1856
Open Access | Times Cited: 96
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
Oliver Howes, Connor Cummings, George E. Chapman, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 151-167
Open Access | Times Cited: 83
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 58
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Chih Hung Lo, Jialiu Zeng
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 92
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
Špela Korat, Natasha Bidesi, Federica Bonanno, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 847-847
Open Access | Times Cited: 88
Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme
Jaya Prabhakaran, Andrei Molotkov, Akiva Mintz, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3208-3208
Open Access | Times Cited: 58
PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective
Sridhar Goud Nerella, Priti Singh, Tulja Sanam, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 58
[18F]Difluorocarbene for positron emission tomography
Jeroen B. I. Sap, Claudio F. Meyer, Joseph Ford, et al.
Nature (2022) Vol. 606, Iss. 7912, pp. 102-108
Closed Access | Times Cited: 49
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman‐Tancredi, Ronan Depoortère, Mark S. Kleven, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107937-107937
Closed Access | Times Cited: 55
Quantitative PET in the 2020s: a roadmap
Steven R. Meikle, Vesna Sossi, Emilie Roncali, et al.
Physics in Medicine and Biology (2020) Vol. 66, Iss. 6, pp. 06RM01-06RM01
Open Access | Times Cited: 54
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization
Mohamed Adil Shah Khoodoruth, Maria Anayali Estudillo‐Guerra, Kevin Pacheco‐Barrios, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 34
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
Daniella Dwir, Inès Khadimallah, Lijing Xin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 309-321
Open Access | Times Cited: 17
The Future of (Radio)‐Labeled Compounds in Research and Development within the Life Science Industry
Volker Derdau, Charles S. Elmore, Thomas Härtung, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 52
Open Access | Times Cited: 17
Progress of RAGE Molecular Imaging in Alzheimer’s Disease
Yanyan Kong, Cuiping Liu, Yinping Zhou, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 44
Current status of PET tracers for the early diagnosis of Alzheimer's disease
Yuying Li, Tianqing Liu, Qi Zeng, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 172, pp. 117546-117546
Closed Access | Times Cited: 5
Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging
Aren van Waarde, Rudi Dierckx, Xiaoyun Zhou, et al.
Medicinal Research Reviews (2017) Vol. 38, Iss. 1, pp. 5-56
Open Access | Times Cited: 40
Advances in simultaneous PET/MR for imaging neuroreceptor function
Christin Y. Sander, Hanne D. Hansen, Hsiao‐Ying Wey
Journal of Cerebral Blood Flow & Metabolism (2020) Vol. 40, Iss. 6, pp. 1148-1166
Open Access | Times Cited: 36
Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study
Nathan J. Kolla, Romina Mizrahi, K. Karas, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1834-1841
Open Access | Times Cited: 33
PET Agents in Dementia: An Overview
Aren van Waarde, Sofia Marcolini, Peter Paul De Deyn, et al.
Seminars in Nuclear Medicine (2021) Vol. 51, Iss. 3, pp. 196-229
Open Access | Times Cited: 30
Radiolabelling small and biomolecules for tracking and monitoring
Martin R. Edelmann
RSC Advances (2022) Vol. 12, Iss. 50, pp. 32383-32400
Open Access | Times Cited: 21
The 18F‐Difluoromethyl Group: Challenges, Impact and Outlook
Joseph Ford, Sebastiano Ortalli, Véronique Gouverneur
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 26
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top